🇺🇸 FDA
Pipeline program

TVB-009

TVB009-IMB-30085

Phase 3 other completed

Quick answer

TVB-009 for Osteoporosis, Postmenopausal is a Phase 3 program (other) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Osteoporosis, Postmenopausal
Phase
Phase 3
Modality
other
Status
completed

Clinical trials